During the past decade, Lyndhurst Gynecologic Associates conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lyndhurst Gynecologic Associates" #1 sponsor was "Ferring Pharmaceuticals" with 4 trials, followed by "Bayer" with 2 trials sponsored, "Inovio Pharmaceuticals" with 2 trials sponsored, "Juniper Pharmaceuticals, Inc." with 2 trials sponsored and "Repros Therapeutics Inc." with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lyndhurst Gynecologic Associates" #1 collaborator was "King Pharmaceuticals is now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Novartis" with 1 trials as a collaborator, "PRA Health Sciences" with 1 trials as a collaborator, "Registrat-Mapi" with 1 trials as a collaborator and "Xanodyne Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Lyndhurst Gynecologic Associates" are "Contraception" (2 trials), "Pregnancy" (2 trials), "Uterine Fibroids" (2 trials), "Aneuploidy" (1 trials) and "Cervical Priming" (1 trials). Many other conditions were trialed in "Lyndhurst Gynecologic Associates" in a lesser frequency.

Most popular intervention types in "Lyndhurst Gynecologic Associates" are "Drug" (15 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "VGX-3100" (2 trials), "8% progesterone vaginal gel" (1 trials), "ASQ-3, Bayley III, Neurologic exam" (1 trials) and "Amolimogene" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lyndhurst Gynecologic Associates" are 17 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Lyndhurst Gynecologic Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Lyndhurst Gynecologic Associates, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Lyndhurst Gynecologic Associates, 2 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".